XTRAPHARMA
Annual accounts 2025
abbreviated format, filed on 29-07-2026, 2 days before the deadlineMoney flows
no detail for 2025Balance sheet
balance sheet total €2.2m on 31-12-2025in euro
in euro
Position in the sector
38.7%
Higher than 46% of 9,901 companies in 2025.
1.55
Higher than 44% of 9,664 companies in 2025.
6.6%
Higher than 64% of 9,779 companies in 2025.
Net result: top quarter · Equity: middle half · Balance sheet total: middle half · Working capital: top quarter
Filed annual accounts
as filed with the National Bank, click a year to choose it| Line | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Balance sheet: assets | ||||||
20/58 |
2.2m | 2.2m | 2.8m | 1.5m | 586,785 | |
21/28 |
105,572 | 119,714 | 56,357 | 45,688 | 36,371 | |
22/27 |
98,672 | 112,814 | 49,457 | 38,788 | 29,471 | |
22 |
14,035 | 17,547 | - | - | - | |
23 |
10,265 | 14,930 | 20,299 | 28,977 | 20,318 | |
24 |
74,372 | 80,338 | 29,158 | 9,810 | 9,153 | |
28 |
6,900 | 6,900 | 6,900 | 6,900 | 6,900 | |
29/58 |
2.1m | 2.1m | 2.8m | 1.4m | 550,414 | |
3 |
443,905 | 737,458 | 742,311 | 243,034 | 37,759 | |
30/36 |
443,905 | 737,458 | 742,311 | 243,034 | - | |
37 |
- | - | - | - | 37,759 | |
40/41 |
1.3m | 1.3m | 1.8m | 1.1m | 497,751 | |
40 |
747,556 | 742,679 | 1.6m | 948,964 | 438,511 | |
41 |
597,995 | 509,512 | 244,279 | 178,449 | 59,240 | |
54/58 |
266,028 | 83,879 | 226,904 | 52,685 | 14,905 | |
490/1 |
6,391 | 1,874 | 5,525 | - | - | |
| Balance sheet: equity and liabilities | ||||||
10/49 |
2.2m | 2.2m | 2.8m | 1.5m | 586,785 | |
10/15 |
839,344 | 756,711 | 673,154 | 563,268 | 220,236 | |
10/11 |
5,000 | 5,000 | 5,000 | 5,000 | 5,000 | |
10 |
- | - | - | 5,000 | - | |
100 |
- | - | - | 30,000 | - | |
101 |
- | - | - | 25,000 | - | |
14 |
834,344 | 751,711 | 668,154 | 558,268 | 215,236 | |
17/49 |
1.3m | 1.4m | 2.2m | 905,552 | 366,548 | |
42/48 |
1.3m | 1.4m | 2.2m | 905,552 | 366,548 | |
42 |
45,326 | 49,994 | 63,000 | - | - | |
43 |
380,000 | 395,371 | 505,000 | - | - | |
430/8 |
380,000 | 395,371 | 505,000 | - | - | |
44 |
675,254 | 863,600 | 1.5m | 720,397 | 284,467 | |
440/4 |
675,254 | 863,600 | 1.5m | 720,397 | 284,467 | |
45 |
167,523 | 129,441 | 103,508 | 185,155 | 72,583 | |
450/3 |
167,523 | 129,441 | 103,508 | 185,155 | 72,583 | |
47/48 |
60,000 | - | - | - | 9,498 | |
| Income statement | ||||||
70 |
- | - | 8.6m | - | - | |
9900 |
228,023 | 158,591 | 168,943 | 459,743 | 290,436 | |
60/61 |
- | - | 8.4m | - | - | |
630 |
32,351 | 25,035 | 9,206 | 4,921 | 1,771 | |
640/8 |
2,952 | 7,053 | 11,165 | 4,858 | 795 | |
66A |
- | 376 | - | - | - | |
9901 |
192,720 | 126,126 | 148,571 | 449,964 | 287,870 | |
75/76B |
8,320 | 450 | 7 | 1,627 | 60 | |
75 |
8,320 | 450 | 7 | 1,627 | 60 | |
65/66B |
20,325 | 17,086 | 7,761 | 638 | 276 | |
65 |
20,325 | 17,086 | 7,761 | 638 | 276 | |
9903 |
180,715 | 109,490 | 140,817 | 450,953 | 287,653 | |
67/77 |
38,082 | 25,933 | 30,931 | 107,922 | 72,417 | |
9904 |
142,634 | 83,557 | 109,886 | 343,031 | 215,236 | |
9905 |
142,634 | 83,557 | 109,886 | 343,031 | 215,236 | |
| Appropriation of the result | ||||||
9906 |
894,344 | 751,711 | 668,154 | 558,268 | 215,236 | |
14P |
751,711 | 668,154 | 558,268 | 215,236 | - | |
694/7 |
60,000 | - | - | - | - | |
694 |
60,000 | - | - | - | - | |
| Document | ||||||
The notes to these accounts have 6 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.
Source: Annual accounts 2025 at the NBB, filed on 29-07-2026.
Filings
each dot is a set of accounts, on the day it reached the National Bank| Financial year | Type | Filed | Reference | Document |
|---|---|---|---|---|
| 31-12-2025 | abbreviated format | 29-07-2026 | 2026-00346675 | |
| 31-12-2024 | full format | 25-11-2025 | 2025-00570223 | |
| 31-12-2023 | micro format | 20-11-2025 | 2025-00568653 | |
| 31-12-2022 | full format | 31-10-2023 | 2023-00499872 | |
| 31-12-2021 | micro format | 10-02-2023 | 2023-00026120 |
Key figures and ratios
per financial year, computed from the annual accounts| Line | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| 225,072 | 151,162 | 157,778 | 454,886 | 289,641 | ||
| 174,985 | 108,592 | 119,092 | 347,952 | 217,007 | ||
| 18,209 | 88,392 | 19,877 | 14,238 | 37,036 | ||
| 182,148 | -143,025 | 174,219 | 37,781 | - | ||
| 733,772 | 636,997 | 616,796 | 517,580 | 183,866 | ||
| - | - | 1.7% | - | - | ||
| 38.7% | 34.5% | 23.7% | 38.3% | 37.5% | ||
| 1.55 | 1.44 | 1.28 | 1.57 | 1.50 | ||
| 1.22 | 0.93 | 0.94 | 1.30 | 1.40 | ||
| 1.58 | 1.90 | 3.22 | 1.61 | 1.66 | ||
| 17.0% | 11.0% | 16.3% | 60.9% | 97.7% | ||
| 6.6% | 3.8% | 3.9% | 23.4% | 36.7% | ||
| 11.07 | 8.85 | 20.33 | over 100 | over 100 | ||
| - | - | 67 days | - | - | ||
| - | - | 65 days | - | - |
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
Investments
fixed assets acquired| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tangible fixed assets | €18,209 | €88,392 | €19,877 | €14,238 | €30,136 |
| Financial fixed assets | - | - | - | - | €6,900 |
| €32,351 | €25,035 | €9,206 | €4,921 | €1,771 |
Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)
Insights on XTRAPHARMA
The operating result for 2025 is 53% higher than in 2024 and the highest since 2022. It is a recovery after the fall in 2024.
Debt's share of the balance-sheet total falls from 65.5% to 61.3%. Equity is higher and debt is lower.
- 2023 Net result -68% on 2022. The accounts now follow the micro format, last year the full format.
- 2022 Net result +59% on 2021. The accounts now follow the full format, last year the micro format.